Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2024

Open Access 01-12-2024 | Insulins | Research

Triglyceride glucose-body mass index as a novel predictor of slow coronary flow phenomenon in patients with ischemia and nonobstructive coronary arteries (INOCA)

Authors: Zhi-peng Li, Juan Chen, Qi Xin, Xiao-yang Pei, Hong-li Wu, Zhi-xu Tan

Published in: BMC Cardiovascular Disorders | Issue 1/2024

Login to get access

Abstract

Background

The triglyceride glucose-body mass index (TyG-BMI index) has been suggested as a novel predictor of insulin resistance. However, its predictive value for slow coronary flow phenomenon (SCFP) in patients with ischemia and nonobstructive coronary arteries (INOCA) remains unclear.

Methods

We consecutively recruited 1625 patients with INOCA from February 2019 to February 2023 and divided them into two groups based on thrombolysis in myocardial infarction (TIMI) frame counts (TFCs): the SCFP group (n = 79) and the control group. A 1:2 age-matched case–control study was then performed. The TyG-BMI index was calculated as ln [plasma triglyceride (mg/dL) × fasting blood glucose (mg/dL)/2] × BMI.

Results

TyG-BMI index in the SCFP group (218.3 ± 25.2 vs 201.0 ± 26.5, P < .001) was significantly higher than in the normal controls. TyG-BMI index also increased with the number of coronary arteries involved in the SCFP. Multivariate logistic regression analysis showed that TyG-BMI, BMI, and TG were independent predictors for SCFP. Receiver operating characteristic (ROC) curve analysis showed that when the TyG-BMI index was above 206.7, the sensitivity and specificity were 88.6% and 68.5%, respectively, with an AUC of 0.809 (95% CI: 0.756–0.863, P = .027). Combined BMI with TG, the TyG-BMI index had a better predictive value for SCFP than BMI and TG (P < .001).

Conclusion

The TyG-BMI index was an independent predictor for SCFP in INOCA patients, and it had a better predictive value than BMI and TG.
Literature
1.
go back to reference Reynolds HR, Picard MH, Spertus JA, Peteiro J, Lopez Sendon JL, Senior R, El-Hajjar MC, Celutkiene J, Shapiro MD, Pellikka PA, Kunichoff DF, Anthopolos R, Alfakih K, Abdul-Nour K, Khouri M, Bershtein L, De Belder M, Poh KK, Beltrame JF, Min JK, Fleg JL, Li Y, Maron DJ, Hochman JS. Natural history of patients with ischemia and no obstructive coronary artery disease: The CIAO-ISCHEMIA study. Circulation. 2021;144(13):1008–23.CrossRefPubMedPubMedCentral Reynolds HR, Picard MH, Spertus JA, Peteiro J, Lopez Sendon JL, Senior R, El-Hajjar MC, Celutkiene J, Shapiro MD, Pellikka PA, Kunichoff DF, Anthopolos R, Alfakih K, Abdul-Nour K, Khouri M, Bershtein L, De Belder M, Poh KK, Beltrame JF, Min JK, Fleg JL, Li Y, Maron DJ, Hochman JS. Natural history of patients with ischemia and no obstructive coronary artery disease: The CIAO-ISCHEMIA study. Circulation. 2021;144(13):1008–23.CrossRefPubMedPubMedCentral
3.
go back to reference Saadat M, Masoudkabir F, Afarideh M, Ghodsi S, Vasheghani-Farahani A. Discrimination between obstructive coronary artery disease and cardiac syndrome X in women with typical angina and positive exercise test; utility of cardiovascular risk calculators. Medicina (Kaunas). 2019;55(1):12.CrossRefPubMed Saadat M, Masoudkabir F, Afarideh M, Ghodsi S, Vasheghani-Farahani A. Discrimination between obstructive coronary artery disease and cardiac syndrome X in women with typical angina and positive exercise test; utility of cardiovascular risk calculators. Medicina (Kaunas). 2019;55(1):12.CrossRefPubMed
4.
go back to reference Wang Y, Jia PY, Chen BJ, Chen Y, Yu H, Yu Y, Yang HM, Jia DL, Ma CY. Evaluation of plasma thrombomodulin in patients with coronary slow flow. Cardiology. 2017;138(3):141–6.CrossRefPubMed Wang Y, Jia PY, Chen BJ, Chen Y, Yu H, Yu Y, Yang HM, Jia DL, Ma CY. Evaluation of plasma thrombomodulin in patients with coronary slow flow. Cardiology. 2017;138(3):141–6.CrossRefPubMed
5.
go back to reference Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, Jacques-Camarena O, Rodríguez-Morán M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.CrossRefPubMed
6.
go back to reference Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17(1):268.CrossRefPubMedPubMedCentral Won KB, Park GM, Lee SE, Cho IJ, Kim HC, Lee BK, Chang HJ. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 2018;17(1):268.CrossRefPubMedPubMedCentral
8.
go back to reference Karczewski J, Śledzińska E, Baturo A, Jończyk I, Maleszko A, Samborski P, Begier-Krasińska B, Dobrowolska A. Obesity and inflammation. Eur Cytokine Netw. 2018;29(3):83–94.CrossRefPubMed Karczewski J, Śledzińska E, Baturo A, Jończyk I, Maleszko A, Samborski P, Begier-Krasińska B, Dobrowolska A. Obesity and inflammation. Eur Cytokine Netw. 2018;29(3):83–94.CrossRefPubMed
9.
go back to reference Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547–63.CrossRefPubMed Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547–63.CrossRefPubMed
10.
go back to reference Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.CrossRefPubMedPubMedCentral Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, Ko YL. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS ONE. 2016;11(3):e0149731.CrossRefPubMedPubMedCentral
11.
go back to reference Dai XT, Kong TZ, Zhang XJ, Luan B, Wang Y, Hou AJ. Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon. BMC Cardiovasc Disord. 2022;22(1):362.CrossRefPubMedPubMedCentral Dai XT, Kong TZ, Zhang XJ, Luan B, Wang Y, Hou AJ. Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon. BMC Cardiovasc Disord. 2022;22(1):362.CrossRefPubMedPubMedCentral
12.
go back to reference Ozcan T, Gen R, Akbay E, Horoz M, Akcay B, Genctoy G, Muslu N, Camsari A, Cicek D, Gok E, Kiykim A. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow. Coron Artery Dis. 2008;19(8):591–5.CrossRefPubMed Ozcan T, Gen R, Akbay E, Horoz M, Akcay B, Genctoy G, Muslu N, Camsari A, Cicek D, Gok E, Kiykim A. The correlation of thrombolysis in myocardial infarction frame count with insulin resistance in patients with slow coronary flow. Coron Artery Dis. 2008;19(8):591–5.CrossRefPubMed
13.
go back to reference Genc Tapar G, Elcik D, Dogan A, Altunel E, Inanc MT, Alcali B, Boylug S, Oguzhan A, Topsakal R, Ergin A, Kalay N. An investigation of the relationship between arterial aortic stiffness and coronary slow flow that was detected during coronary angiography. Echocardiography. 2020;37(4):528–35.CrossRefPubMed Genc Tapar G, Elcik D, Dogan A, Altunel E, Inanc MT, Alcali B, Boylug S, Oguzhan A, Topsakal R, Ergin A, Kalay N. An investigation of the relationship between arterial aortic stiffness and coronary slow flow that was detected during coronary angiography. Echocardiography. 2020;37(4):528–35.CrossRefPubMed
14.
go back to reference Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–88.CrossRefPubMed Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879–88.CrossRefPubMed
15.
go back to reference Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon: a new coronary microvascular disorder. Cardiology. 2002;97(4):197–202.CrossRefPubMed Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon: a new coronary microvascular disorder. Cardiology. 2002;97(4):197–202.CrossRefPubMed
16.
go back to reference Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology. 2001;52(8):507–14.CrossRefPubMed Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology. 2001;52(8):507–14.CrossRefPubMed
17.
go back to reference Yesin M, Çağdaş M, Karabağ Y, Rencüzoğullari İ, Burak C, Kalçik M, Gürsoy MO, Karakoyun S. Assessment of the relationship between C-reactive protein-to-albumin ratio and slow coronary flow in patients with stable angina pectoris. Coron Artery Dis. 2019;30(7):505–10.CrossRefPubMed Yesin M, Çağdaş M, Karabağ Y, Rencüzoğullari İ, Burak C, Kalçik M, Gürsoy MO, Karakoyun S. Assessment of the relationship between C-reactive protein-to-albumin ratio and slow coronary flow in patients with stable angina pectoris. Coron Artery Dis. 2019;30(7):505–10.CrossRefPubMed
18.
go back to reference Camsari A, Ozcan T, Ozer C, Akcay B. Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis. 2008;200(2):310–4.CrossRefPubMed Camsari A, Ozcan T, Ozer C, Akcay B. Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis. 2008;200(2):310–4.CrossRefPubMed
19.
go back to reference Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, Katýrcýbaý T, Döven O. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 2003;44(6):907–19.CrossRefPubMed Cin VG, Pekdemir H, Camsar A, Ciçek D, Akkus MN, Parmaksýz T, Katýrcýbaý T, Döven O. Diffuse intimal thickening of coronary arteries in slow coronary flow. Jpn Heart J. 2003;44(6):907–19.CrossRefPubMed
20.
go back to reference Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.CrossRefPubMedPubMedCentral
21.
go back to reference Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. The impact of the triglyceride-glucose index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021;12:710240.CrossRef Yang J, Tang YD, Zheng Y, Li C, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C. The impact of the triglyceride-glucose index on poor prognosis in nondiabetic patients undergoing percutaneous coronary intervention. Front Endocrinol. 2021;12:710240.CrossRef
22.
go back to reference Wang Y, Wang Y, Sun S, Liu X, Zhao W, Li W, Suo M, Wu Z, Wu X. Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study. Lipids Health Dis. 2022;21(1):134.CrossRefPubMedPubMedCentral Wang Y, Wang Y, Sun S, Liu X, Zhao W, Li W, Suo M, Wu Z, Wu X. Triglyceride-glucose index level and variability and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational cohort study. Lipids Health Dis. 2022;21(1):134.CrossRefPubMedPubMedCentral
23.
go back to reference Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.CrossRefPubMedPubMedCentral Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, Xie Y, Yang C, Jin P, Wang F. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.CrossRefPubMedPubMedCentral
24.
go back to reference Chen S, Mei Q, Guo L, Yang X, Luo W, Qu X, Li X, Zhou B, Chen K, Zeng C. Association between triglyceride-glucose index and atrial fibrillation: A retrospective observational study. Front Endocrinol (Lausanne). 2022;13:1047927.CrossRefPubMed Chen S, Mei Q, Guo L, Yang X, Luo W, Qu X, Li X, Zhou B, Chen K, Zeng C. Association between triglyceride-glucose index and atrial fibrillation: A retrospective observational study. Front Endocrinol (Lausanne). 2022;13:1047927.CrossRefPubMed
25.
go back to reference Guo X, Shen R, Yan S, Su Y, Ma L. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):43.CrossRefPubMedPubMedCentral Guo X, Shen R, Yan S, Su Y, Ma L. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention. Cardiovasc Diabetol. 2023;22(1):43.CrossRefPubMedPubMedCentral
26.
go back to reference Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao Y, Chen C, Jia H, Chu C, Zheng W, Hu J, Yuan Y, Wang Y, Wu Y, Mu J. Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study. Cardiovasc Diabetol. 2022;21(1):33.CrossRefPubMedPubMedCentral Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao Y, Chen C, Jia H, Chu C, Zheng W, Hu J, Yuan Y, Wang Y, Wu Y, Mu J. Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study. Cardiovasc Diabetol. 2022;21(1):33.CrossRefPubMedPubMedCentral
27.
go back to reference Wang M, Mei L, Jin A, Cai X, Jing J, Wang S, Meng X, Li S, Wei T, Wang Y, Pan Y. Association between triglyceride glucose index and atherosclerotic plaques and Burden: findings from a community-based study. Cardiovasc Diabetol. 2022;21(1):204.CrossRefPubMedPubMedCentral Wang M, Mei L, Jin A, Cai X, Jing J, Wang S, Meng X, Li S, Wei T, Wang Y, Pan Y. Association between triglyceride glucose index and atherosclerotic plaques and Burden: findings from a community-based study. Cardiovasc Diabetol. 2022;21(1):204.CrossRefPubMedPubMedCentral
28.
go back to reference Li W, Chen D, Tao Y, Lu Z, Wang D. Association between triglyceride-glucose index and carotid atherosclerosis detected by ultrasonography. Cardiovasc Diabetol. 2022;21(1):137.CrossRefPubMedPubMedCentral Li W, Chen D, Tao Y, Lu Z, Wang D. Association between triglyceride-glucose index and carotid atherosclerosis detected by ultrasonography. Cardiovasc Diabetol. 2022;21(1):137.CrossRefPubMedPubMedCentral
29.
go back to reference Yuksel Y, Yildiz C. Evaluation of triglyceride-glucose index in coronary slow flow patients. Kardiologiia. 2023;63(5):62–7.CrossRefPubMed Yuksel Y, Yildiz C. Evaluation of triglyceride-glucose index in coronary slow flow patients. Kardiologiia. 2023;63(5):62–7.CrossRefPubMed
30.
go back to reference Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.CrossRefPubMed Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.CrossRefPubMed
31.
go back to reference Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487–95.CrossRefPubMedPubMedCentral Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487–95.CrossRefPubMedPubMedCentral
32.
go back to reference Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.CrossRefPubMedPubMedCentral Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.CrossRefPubMedPubMedCentral
33.
go back to reference Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow- prevalence and clinical correlations. Circ J. 2012;76(4):936–42.CrossRefPubMed Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow- prevalence and clinical correlations. Circ J. 2012;76(4):936–42.CrossRefPubMed
Metadata
Title
Triglyceride glucose-body mass index as a novel predictor of slow coronary flow phenomenon in patients with ischemia and nonobstructive coronary arteries (INOCA)
Authors
Zhi-peng Li
Juan Chen
Qi Xin
Xiao-yang Pei
Hong-li Wu
Zhi-xu Tan
Publication date
01-12-2024
Publisher
BioMed Central
Keywords
Insulins
Insulins
Published in
BMC Cardiovascular Disorders / Issue 1/2024
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-024-03722-4

Other articles of this Issue 1/2024

BMC Cardiovascular Disorders 1/2024 Go to the issue